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Purpose of Supplement
This Supplement provides additional details related to the synthesis and crystallization of insulin analogs, refinement statistics and contains eight supplement figures and six supplemental tables. Figure  S1 extends Figure 4 in the main text to illustrate the position of His B5 in the R f 3 trimer interface within the T 3 R f 3 zinc hexamer. Figure S2 further illustrates the structural relationships in Figures 4 and S1, providing residue-specific labeling and corresponding space-filling models. In Figure S3 are shown 1 H-NMR spectra of the wild-type R 6 hexamer and the perturbed spectrum of Arg B5 -insulin under the same conditions. Figure S4 depicts the crystal structure of Arg B5 -insulin as a hexamer, highlighting the solvent-exposed position of the B5 side chain. In Figure S5 we illustrate the similarity of the structure of Arg B5 -insulin protomers in the T-and R-states to an extensive collection of wild-type crystallographic protomers; also shown are space-filling models providing an alternative visualization of the structures shown in Figure 3 (main text). The two axial zinc-binding sites in the T 6 hexamer are shown in Figure  S6 . Respective local environment of the Arg B5 side chains in molecules 1 and 2 are shown in Figure S7 , including inter-chain hydrogen bonds from the B5 N ε H functional group. Figure S8 illustrates how Arg B5 alters the electrostatic surface of insulin near its putative receptor-binding surface. Table S1 provides diffraction statistics related to X-ray crystallography. Tables S2 and S3 provide structural comparisons (root-mean-square deviations; RMSD) between Arg B5 -insulin (molecules 1 and 2, respectively) and multiple wild-type insulin T-state protomers. The main-chain conformations of residue B5 in multiple wild-type insulin protomers are provided in Table S4 . Contacts to the side chain of Arg B5 within molecules 1 and 2 are provided in Tables S5-A and S5-B, respectively. Additional contacts to symmetry-related protomers are provided in Table S6 .
Supplemental EXPERIMENTAL PROCEDURES
Synthesis of Insulin Analogs. The tetra-S-sulfonate derivative of the human A-chain was obtained by oxidative sulfitolysis (1) . Arg B5 and Met B5 B-chain analogs were prepared by solid-phase chemical synthesis (1) . Whereas the Met B5 B-chain was unable to undergo chain combination, the efficiency of Arg B5 chain combination was 35-40% of that obtained in a control synthesis of wild-type insulin. While this reaction is generally robust, its efficiency can be impaired by a subset of substitutions that introduce kinetic barriers to specific disulfide pairing (1) (2) (3) (4) (5) . Substitution of His B5 by Ala, for example, leads to a 12-fold decrease in yield (relative to the wild-type reaction), presumably due to loss of key inter-chain contacts in an oxidative intermediate (6) . By contrast, the yield of Arg B5 -insulin was only modestly reduced: 5-fold improved efficiency of Arg B5 -related chain combination relative was observed relative to Ala B5 . This improvement is likely to be due to favorable nativelike interactions by the guanidinium group of Arg B5 rather than increased side-chain volume as essentially no product was obtained in an attempted control synthesis of Met B8 -insulin. The predicted molecular mass of ArgB5-insulin was confirmed by matrix-assisted laser-desorption ionization mass spectrometry. Because of its impaired chain combination, characterization of Met B5 -insulin could not be undertaken.
X-ray Crystallography. Crystals were grown by hanging-drop vapor diffusion in the presence of a 1:2.5 ratio of Zn 2+ to protein monomer and a 3.7:1 ratio of phenol to protein monomer in Tris-HCl buffer (pH 8.0) as described (7) . Drops consisted of 1 μl of protein solution (10 mg/ml in 0.02 M HCl) mixed with 1 μl of reservoir solution (0.02 M Tris-HCl, 0.05 M sodium citrate, 5% acetone, 0.03% phenol, and 0.01% zinc acetate at pH 8.0). Each drop was suspended over 1 ml of reservoir solution. Crystals were obtained at room temperature after two weeks. ) 17.1_______________ a Values in parentheses refer to the high resolution shell. b R mere = ∑∑│I(h) I -<I(h)>│/ ∑∑ I(h) I , where I(h) I is the observed intensity of the ith source and <I(h)> is the mean intensity of reflection h over all measurements of I(h). c R cryst = ∑│F obc │ -│F calc │/ ∑│F obs │, where │F obc │ and │F calc │ are the observed and calculated structure factor amplitude, respectively. d R free is equivalent to R crys except that it concerns 10% of the total reflections that were omitted in the refinement process.__________________________ Structures were pairwise aligned according to the mainchain atoms of residues B3-B28 and A2-A20. Structures were pairwise aligned according to the mainchain atoms of residues B3-B28 and A2-A20. 
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